➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Mallinckrodt
Baxter
Medtronic

Last Updated: October 27, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FONDAPARINUX SODIUM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Fondaparinux Sodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00038961 A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased R Completed Sanofi Phase 3 2001-11-01 This is a multicentre, randomized, double-blind, placebo controlled study. During this study all the patients will receive background venous thromboembolism (VTE) mechanical prophylaxis with intermittent pneumatic compression (IPC).
NCT00038961 A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased R Completed GlaxoSmithKline Phase 3 2001-11-01 This is a multicentre, randomized, double-blind, placebo controlled study. During this study all the patients will receive background venous thromboembolism (VTE) mechanical prophylaxis with intermittent pneumatic compression (IPC).
NCT00320398 Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) Completed GlaxoSmithKline Phase 3 2006-01-01 This study is requested by PMDA to confirm the optimal dose for THR (total hip replacement).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fondaparinux Sodium

Condition Name

Condition Name for Fondaparinux Sodium
Intervention Trials
Venous Thromboembolism 3
Thrombosis, Venous 3
Venous Thrombosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fondaparinux Sodium
Intervention Trials
Thrombosis 8
Venous Thrombosis 7
Thromboembolism 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fondaparinux Sodium

Trials by Country

Trials by Country for Fondaparinux Sodium
Location Trials
United States 10
Germany 10
Italy 9
Japan 3
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fondaparinux Sodium
Location Trials
Pennsylvania 2
Maryland 1
New York 1
Alabama 1
Michigan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fondaparinux Sodium

Clinical Trial Phase

Clinical Trial Phase for Fondaparinux Sodium
Clinical Trial Phase Trials
Phase 4 1
Phase 3 8
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fondaparinux Sodium
Clinical Trial Phase Trials
Completed 12
Unknown status 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fondaparinux Sodium

Sponsor Name

Sponsor Name for Fondaparinux Sodium
Sponsor Trials
GlaxoSmithKline 13
University of Pittsburgh 1
Wayne State University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fondaparinux Sodium
Sponsor Trials
Industry 15
Other 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.